Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

10/02/2023 08:00

Feb 10 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            699 mln             335 mln                    
                (+108.7 pct)        (+109.4 pct)                  
  Operating     loss 904 mln          loss 1.71                   
  Recurring     loss 928 mln          loss 1.72                   
  Net           loss 913 mln          loss 2.14                   
  EPS           loss 4.74 yen      loss 11.52 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T